Performance analysis of Ovid Therapeutics (OVID)
Annual Return
Over the past 3 years, OVID has had an average annual return of -12.22%, underperforming the benchmark SPY, which returned +19.62% annual.
Over the past 5 years, OVID has had an average annual return of -8.81%, underperforming the benchmark SPY, which returned +12.73% annual.
Since May 5, 2017, OVID has had an average annual return of -16.17%, underperforming the benchmark SPY, which returned +14.95% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +47.78% | +74.67% | -71.02% | +73.19% | -42.06% | +38.92% | -44.33% | +71.46% | -75.47% | -19.43% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -4.36% | +4.56% | +36.14% | +24.78% | -1.42% | -1.48% | -10.43% | +47.78% | |||||
| 2025 | -28.87% | -20.11% | -41.11% | +4.71% | -16.85% | +21.17% | +51.67% | +156.13% | +1.53% | +6.97% | +28.02% | -8.40% | +74.67% |
| 2024 | +20.16% | -12.12% | -10.30% | -0% | +0.32% | -74.86% | +35.19% | +8.60% | +4.45% | -4.26% | +0.98% | -18.15% | -71.02% |
| 2023 | +34.45% | -1.22% | +4.46% | +38.75% | -1.10% | -7.34% | +9.45% | -6.28% | +14.12% | -7.56% | -16.18% | +8.23% | +73.19% |
| 2022 | -14.01% | +22.81% | -7.37% | -12.41% | -38.53% | +27.17% | -4.67% | -1.91% | -8.47% | -11.38% | +8.56% | +5.05% | -42.06% |
| 2021 | +21.63% | +4.97% | +36.30% | -8.71% | +13.08% | -5.79% | -4.61% | -5.35% | -4.82% | +1.20% | -1.48% | -4.20% | +38.92% |
| 2020 | -13.25% | -8.88% | -9.15% | +22.11% | +46.99% | +37.76% | -12.48% | -11.00% | -0% | -10.99% | +33.88% | -66.22% | -44.33% |
| 2019 | +16.90% | -27.19% | -14.09% | +15.22% | -21.56% | +15.62% | +10.26% | -13.21% | +83.04% | -28.70% | +84.41% | -2.59% | +71.46% |
| 2018 | -13.88% | -22.47% | +7.27% | +34.10% | -16.77% | -1.15% | +27.96% | -33.17% | -14.99% | -9.53% | -21.44% | -39.94% | -75.47% |
| 2017 | +4.08% | -17.73% | -21.92% | +15.02% | -9.02% | -24.39% | +89.96% | -19.82% | -19.43% |
Drawdown analysis of Ovid Therapeutics (OVID)
The maximum drawdown for the OVID was -98.30%, occurring on Apr 8, 2025. This drawdown has not yet recovered.
The current OVID drawdown is -83.94%.
Since May 5, 2017 OVID has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -98.30% | May 19, 2017 | 1982 | Apr 8, 2025 | Ongoing | Ongoing | Ongoing |
| -1.29% | May 15, 2017 | 2 | May 17, 2017 | 1 | May 18, 2017 | 3 |
| -0.79% | May 11, 2017 | 1 | May 12, 2017 | 1 | May 15, 2017 | 2 |